CustomerInsights.AI Secures Non-Dilutive Capital Investment from Cypress Growth Capital

CustomerInsights.AI, Inc. (CIAI) has announced a significant capital investment from Cypress Growth Capital. This injection of non-dilutive growth capital is aimed at propelling the company’s initiatives in marketing, sales, and the expansion of agentic AI capabilities in the life sciences sector.

Abhay Jajoo, Co-founder and CEO of CIAI, expressed the importance of this funding, stating, "CIAI is addressing a vital need within the Life Sciences commercial analytics realm. Securing outside investment will facilitate our scalability in market outreach while ensuring the ongoing development of our platform." The CEO elaborated on the decision-making process, noting that the company considered multiple options for growth capital partners. Ultimately, CIAI chose Cypress due to their understanding of their unique needs and challenges.

Cypress Growth Capital brings a wealth of experience with technology investments and operates with an innovative approach—providing non-dilutive, multi-tranche capital that allows CIAI to execute its growth strategy without diluting ownership for founders and key employees.

The decision from Cypress to invest in CIAI was influenced by the profound industry knowledge of the CIAI team and their impressive track record. Vik Thapar, Managing Director at Cypress, acknowledged CIAI's position in the market, stating, "CIAI has emerged as a leader in a rapidly expanding market segment. The team has effectively harnessed their extensive hands-on experience in pharmaceutical data to build a robust technology platform, complemented by specialized consulting solutions. Their transformative approach to how Life Sciences companies make critical market decisions is commendable. We take pride in partnering with the CIAI team during their growth journey."

About CustomerInsights.AI (CIAI)

Founded in 2018, CustomerInsights.AI is a Platform-led Analytics as a Service (PLAaaS) enterprise that is revolutionizing the Life Sciences analytics landscape through an array of AI-driven commercial analytics applications tailored for pharmaceutical and biotech clients. For further details, visit CustomerInsights.AI or connect on LinkedIn.

About Cypress Growth Capital

Cypress Growth Capital offers a novel alternative to traditional equity and debt funding for entrepreneurs looking at growth funding options. Their strategy preserves equity, maintains flexibility, and empowers business control for the entrepreneur. Moreover, portfolio companies benefit from tangible guidance through their high-growth phases, drawing from the operational experience of their investment partners. Since 2011, Cypress has supported growth ventures for sixty successful software and technology-enabled service companies. For more information, check out Cypress Growth Capital or on LinkedIn.

Through this strategic partnership, both CIAI and Cypress Growth Capital are set to forge new paths in the Life Sciences sector, focusing on innovation-driven analytics and robust growth in commercial effectiveness.